Showing 8231-8240 of 10904 results for "".
Counseling Patients on Their Future with Biologics
https://practicaldermatology.com/videos/dermatology-hub-neuroimmune-network/counseling-patients-on-their-future-with-biologics/57010/Practical Dermatology Editorial Board member Amy L. Spizuoco, DO, FAOCD, FAAD, describes the conversations she has with patients with atopic dermatitis who may be hesitant about remaining on a biologic treatment long-term.A Comprehensive Approach to Hair Loss Restoration
https://practicaldermatology.com/videos/skin-minute/a-comprehensive-approach-to-hair-loss-restoration/85624/Dr. Jeanine Downie, a board-certified cosmetic dermatologist, shares some of her insights and expertise from her presentation at the recent 2026 Skin of Color Update meeting in New York City, regarding her multi-modal approach to treating hair loss across all skin types and hair textures, includingDifferentiating Atopic Dermatitis From Psoriasis and CTCL
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/differentiating-atopic-dermatitis-from-psoriasis-and-ctcl/48778/Christopher Bunick, MD, FAAD, discusses the overlap in gene expression and cytokine signaling between atopic dermatitis and psoriasis, the possibility of CTCL mimicking atopic dermatitis, and the utility of a skin biopsy in some cases to differentiate.Build a Better Relationship with Your Dermatopathologist
https://practicaldermatology.com/topics/skin-cancer-photoprotection/build-a-better-relationship-with-your-dermatopathologist/18532/A strong relationship between the dermatologist and dermatopathologist is essential in achieving the best diagnosis for the patient. Abel Jarell, MD offers insights for helping your dermatopathologist work smarter for you and how to avoid potential pitfalls.Practical Dermatology Roundtable: Alopecia Areata Burden, Ch. 5
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-alopecia-areata-burden-ch-5/68943/In the fifth installment of this five-part series during Alopecia Areata Awareness Month, host Natasha Atanaskova Mesinkovska, MD, PhD, and guests Maryanne Senna, MD, and Chesahna Kindred, MD, MBA, FAAD, discuss prescribing systemic therapies for pediatric patients with alopecia areata.TBDPractical Dermatology Roundtable: Alopecia Areata Burden, Ch. 3
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-alopecia-areata-burden-ch-3/68941/In the third installment of this five-part series during Alopecia Areata Awareness Month, host Natasha Atanaskova Mesinkovska, MD, PhD, and guests Maryanne Senna, MD, and Chesahna Kindred, MD, MBA, FAAD, discuss the therapeutic options available for alopecia areata and the key factors in selecting aDermWireTV: Inclusion in Derm; Amgen, Incyte, Janssen, Dermavant Updates; Klisyri Launch; More
https://practicaldermatology.com/topics/practice-management/dermwiretv-inclusion-in-derm-amgen-incyte-janssen-dermavant-updates-klisyri-launch-more/19901/For an article in Pediatric Dermatology, Linda Oyesiku, MPH, a student member of the Society for Pediatric Dermatology, describes historical obstacles to inclusion and highlights opportunities to expand representation and reduce bias in dermatology. Research conducted by The Martec Group using theirExpanding the Role of Topicals in Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-updates-in-atopic-dermatitis/expanding-the-role-of-topicals-in-atopic-dermatitis/57282/Tina Bhutani-Jacques, MD, MAS, discusses how newer nonsteroidal topical therapies are changing the treatment paradigm in atopic dermatitis, expanding options for patients across disease severities and supporting long-term disease management.Atopic Dermatitis in the Real World
https://practicaldermatology.com/videos/dermatology-hub-neuroimmune-network/atopic-dermatitis-in-the-real-world/57014/Emma Guttman, MD, PhD, discusses the disconnect that sometimes exists in atopic dermatitis between clinical trials and real-world situations.First, Do No Harm
https://practicaldermatology.com/conferences/scale-2023/first-do-no-harm/20206/Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss why dermatologists should report any side effects to the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database.